0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inflammatory POCT Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-36K13727
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Inflammatory POCT Market Research Report 2023
BUY CHAPTERS

Global Inflammatory POCT Market Research Report 2025

Code: QYRE-Auto-36K13727
Report
May 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inflammatory POCT Market

The global market for Inflammatory POCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Inflammatory POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inflammatory POCT is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Inflammatory POCT include Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inflammatory POCT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory POCT.
The Inflammatory POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inflammatory POCT market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inflammatory POCT manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inflammatory POCT Market Report

Report Metric Details
Report Name Inflammatory POCT Market
Segment by Type
Segment by Application
  • C-Reactive Protein (CRP) Test
  • Procalcitonin (PCT) Test
  • Interleukin 6 (IL-6) Test
  • Serum amyloid A (SAA) Test
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., Shanghai Upper Bio-Tech Pharma Co.,Ltd., Qingdao Hightop Biotech Co., Ltd., Goldsite Diagnostics Inc., Genrui Biotech Inc, Hipro Biotechnology CO.,LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inflammatory POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inflammatory POCT in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Inflammatory POCT Market report?

Ans: The main players in the Inflammatory POCT Market are Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., Shanghai Upper Bio-Tech Pharma Co.,Ltd., Qingdao Hightop Biotech Co., Ltd., Goldsite Diagnostics Inc., Genrui Biotech Inc, Hipro Biotechnology CO.,LTD

What are the Application segmentation covered in the Inflammatory POCT Market report?

Ans: The Applications covered in the Inflammatory POCT Market report are C-Reactive Protein (CRP) Test, Procalcitonin (PCT) Test, Interleukin 6 (IL-6) Test, Serum amyloid A (SAA) Test, Others

What are the Type segmentation covered in the Inflammatory POCT Market report?

Ans: The Types covered in the Inflammatory POCT Market report are Based on Immunochromatography, Based on Chemiluminescence, Based on Microfluidic Chip

Recommended Reports

POCT Diagnostics

Anti-Inflammatory Drugs

Immunology & Infection

1 Inflammatory POCT Market Overview
1.1 Product Definition
1.2 Inflammatory POCT by Type
1.2.1 Global Inflammatory POCT Market Value Comparison by Type (2024 VS 2031)
1.2.2 Based on Immunochromatography
1.2.3 Based on Chemiluminescence
1.2.4 Based on Microfluidic Chip
1.3 Inflammatory POCT by Application
1.3.1 Global Inflammatory POCT Market Value by Application (2024 VS 2031)
1.3.2 C-Reactive Protein (CRP) Test
1.3.3 Procalcitonin (PCT) Test
1.3.4 Interleukin 6 (IL-6) Test
1.3.5 Serum amyloid A (SAA) Test
1.3.6 Others
1.4 Global Inflammatory POCT Market Size Estimates and Forecasts
1.4.1 Global Inflammatory POCT Revenue 2020-2031
1.4.2 Global Inflammatory POCT Sales 2020-2031
1.4.3 Global Inflammatory POCT Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inflammatory POCT Market Competition by Manufacturers
2.1 Global Inflammatory POCT Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inflammatory POCT Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inflammatory POCT Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inflammatory POCT, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inflammatory POCT, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inflammatory POCT, Product Type & Application
2.7 Global Key Manufacturers of Inflammatory POCT, Date of Enter into This Industry
2.8 Global Inflammatory POCT Market Competitive Situation and Trends
2.8.1 Global Inflammatory POCT Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inflammatory POCT Players Market Share by Revenue
2.8.3 Global Inflammatory POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inflammatory POCT Market Scenario by Region
3.1 Global Inflammatory POCT Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inflammatory POCT Sales by Region: 2020-2031
3.2.1 Global Inflammatory POCT Sales by Region: 2020-2025
3.2.2 Global Inflammatory POCT Sales by Region: 2026-2031
3.3 Global Inflammatory POCT Revenue by Region: 2020-2031
3.3.1 Global Inflammatory POCT Revenue by Region: 2020-2025
3.3.2 Global Inflammatory POCT Revenue by Region: 2026-2031
3.4 North America Inflammatory POCT Market Facts & Figures by Country
3.4.1 North America Inflammatory POCT Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inflammatory POCT Sales by Country (2020-2031)
3.4.3 North America Inflammatory POCT Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inflammatory POCT Market Facts & Figures by Country
3.5.1 Europe Inflammatory POCT Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inflammatory POCT Sales by Country (2020-2031)
3.5.3 Europe Inflammatory POCT Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inflammatory POCT Market Facts & Figures by Region
3.6.1 Asia Pacific Inflammatory POCT Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inflammatory POCT Sales by Region (2020-2031)
3.6.3 Asia Pacific Inflammatory POCT Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inflammatory POCT Market Facts & Figures by Country
3.7.1 Latin America Inflammatory POCT Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inflammatory POCT Sales by Country (2020-2031)
3.7.3 Latin America Inflammatory POCT Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inflammatory POCT Market Facts & Figures by Country
3.8.1 Middle East and Africa Inflammatory POCT Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inflammatory POCT Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inflammatory POCT Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inflammatory POCT Sales by Type (2020-2031)
4.1.1 Global Inflammatory POCT Sales by Type (2020-2025)
4.1.2 Global Inflammatory POCT Sales by Type (2026-2031)
4.1.3 Global Inflammatory POCT Sales Market Share by Type (2020-2031)
4.2 Global Inflammatory POCT Revenue by Type (2020-2031)
4.2.1 Global Inflammatory POCT Revenue by Type (2020-2025)
4.2.2 Global Inflammatory POCT Revenue by Type (2026-2031)
4.2.3 Global Inflammatory POCT Revenue Market Share by Type (2020-2031)
4.3 Global Inflammatory POCT Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inflammatory POCT Sales by Application (2020-2031)
5.1.1 Global Inflammatory POCT Sales by Application (2020-2025)
5.1.2 Global Inflammatory POCT Sales by Application (2026-2031)
5.1.3 Global Inflammatory POCT Sales Market Share by Application (2020-2031)
5.2 Global Inflammatory POCT Revenue by Application (2020-2031)
5.2.1 Global Inflammatory POCT Revenue by Application (2020-2025)
5.2.2 Global Inflammatory POCT Revenue by Application (2026-2031)
5.2.3 Global Inflammatory POCT Revenue Market Share by Application (2020-2031)
5.3 Global Inflammatory POCT Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Inflammatory POCT Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Inflammatory POCT Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Siemens Healthineers
6.3.1 Siemens Healthineers Company Information
6.3.2 Siemens Healthineers Description and Business Overview
6.3.3 Siemens Healthineers Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Siemens Healthineers Inflammatory POCT Product Portfolio
6.3.5 Siemens Healthineers Recent Developments/Updates
6.4 BioMerieux
6.4.1 BioMerieux Company Information
6.4.2 BioMerieux Description and Business Overview
6.4.3 BioMerieux Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioMerieux Inflammatory POCT Product Portfolio
6.4.5 BioMerieux Recent Developments/Updates
6.5 Bio-Rad Laboratories
6.5.1 Bio-Rad Laboratories Company Information
6.5.2 Bio-Rad Laboratories Description and Business Overview
6.5.3 Bio-Rad Laboratories Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bio-Rad Laboratories Inflammatory POCT Product Portfolio
6.5.5 Bio-Rad Laboratories Recent Developments/Updates
6.6 Assure Tech
6.6.1 Assure Tech Company Information
6.6.2 Assure Tech Description and Business Overview
6.6.3 Assure Tech Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Assure Tech Inflammatory POCT Product Portfolio
6.6.5 Assure Tech Recent Developments/Updates
6.7 Guangzhou Wondfo Biotech Co.,Ltd.
6.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
6.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
6.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Product Portfolio
6.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
6.8 Wuhan Easy Diagnosis
6.8.1 Wuhan Easy Diagnosis Company Information
6.8.2 Wuhan Easy Diagnosis Description and Business Overview
6.8.3 Wuhan Easy Diagnosis Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wuhan Easy Diagnosis Inflammatory POCT Product Portfolio
6.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
6.9 Getein Biotech
6.9.1 Getein Biotech Company Information
6.9.2 Getein Biotech Description and Business Overview
6.9.3 Getein Biotech Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Getein Biotech Inflammatory POCT Product Portfolio
6.9.5 Getein Biotech Recent Developments/Updates
6.10 Beijing Hotgen Biotech Co.,ltd.
6.10.1 Beijing Hotgen Biotech Co.,ltd. Company Information
6.10.2 Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
6.10.3 Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Product Portfolio
6.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
6.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
6.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Company Information
6.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Description and Business Overview
6.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Product Portfolio
6.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
6.12 Qingdao Hightop Biotech Co., Ltd.
6.12.1 Qingdao Hightop Biotech Co., Ltd. Company Information
6.12.2 Qingdao Hightop Biotech Co., Ltd. Description and Business Overview
6.12.3 Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Product Portfolio
6.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
6.13 Goldsite Diagnostics Inc.
6.13.1 Goldsite Diagnostics Inc. Company Information
6.13.2 Goldsite Diagnostics Inc. Description and Business Overview
6.13.3 Goldsite Diagnostics Inc. Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Goldsite Diagnostics Inc. Inflammatory POCT Product Portfolio
6.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
6.14 Genrui Biotech Inc
6.14.1 Genrui Biotech Inc Company Information
6.14.2 Genrui Biotech Inc Description and Business Overview
6.14.3 Genrui Biotech Inc Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Genrui Biotech Inc Inflammatory POCT Product Portfolio
6.14.5 Genrui Biotech Inc Recent Developments/Updates
6.15 Hipro Biotechnology CO.,LTD
6.15.1 Hipro Biotechnology CO.,LTD Company Information
6.15.2 Hipro Biotechnology CO.,LTD Description and Business Overview
6.15.3 Hipro Biotechnology CO.,LTD Inflammatory POCT Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hipro Biotechnology CO.,LTD Inflammatory POCT Product Portfolio
6.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inflammatory POCT Industry Chain Analysis
7.2 Inflammatory POCT Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inflammatory POCT Production Mode & Process Analysis
7.4 Inflammatory POCT Sales and Marketing
7.4.1 Inflammatory POCT Sales Channels
7.4.2 Inflammatory POCT Distributors
7.5 Inflammatory POCT Customer Analysis
8 Inflammatory POCT Market Dynamics
8.1 Inflammatory POCT Industry Trends
8.2 Inflammatory POCT Market Drivers
8.3 Inflammatory POCT Market Challenges
8.4 Inflammatory POCT Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inflammatory POCT Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inflammatory POCT Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inflammatory POCT Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inflammatory POCT Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Inflammatory POCT Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inflammatory POCT Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inflammatory POCT Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inflammatory POCT Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inflammatory POCT, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inflammatory POCT, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inflammatory POCT, Product Type & Application
 Table 12. Global Key Manufacturers of Inflammatory POCT, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inflammatory POCT by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory POCT as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inflammatory POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inflammatory POCT Sales by Region (2020-2025) & (K Units)
 Table 18. Global Inflammatory POCT Sales Market Share by Region (2020-2025)
 Table 19. Global Inflammatory POCT Sales by Region (2026-2031) & (K Units)
 Table 20. Global Inflammatory POCT Sales Market Share by Region (2026-2031)
 Table 21. Global Inflammatory POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inflammatory POCT Revenue Market Share by Region (2020-2025)
 Table 23. Global Inflammatory POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inflammatory POCT Revenue Market Share by Region (2026-2031)
 Table 25. North America Inflammatory POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inflammatory POCT Sales by Country (2020-2025) & (K Units)
 Table 27. North America Inflammatory POCT Sales by Country (2026-2031) & (K Units)
 Table 28. North America Inflammatory POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inflammatory POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inflammatory POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inflammatory POCT Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Inflammatory POCT Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Inflammatory POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inflammatory POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inflammatory POCT Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inflammatory POCT Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Inflammatory POCT Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Inflammatory POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inflammatory POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inflammatory POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inflammatory POCT Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Inflammatory POCT Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Inflammatory POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inflammatory POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inflammatory POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inflammatory POCT Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Inflammatory POCT Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Inflammatory POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inflammatory POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inflammatory POCT Sales (K Units) by Type (2020-2025)
 Table 51. Global Inflammatory POCT Sales (K Units) by Type (2026-2031)
 Table 52. Global Inflammatory POCT Sales Market Share by Type (2020-2025)
 Table 53. Global Inflammatory POCT Sales Market Share by Type (2026-2031)
 Table 54. Global Inflammatory POCT Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inflammatory POCT Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inflammatory POCT Revenue Market Share by Type (2020-2025)
 Table 57. Global Inflammatory POCT Revenue Market Share by Type (2026-2031)
 Table 58. Global Inflammatory POCT Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Inflammatory POCT Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Inflammatory POCT Sales (K Units) by Application (2020-2025)
 Table 61. Global Inflammatory POCT Sales (K Units) by Application (2026-2031)
 Table 62. Global Inflammatory POCT Sales Market Share by Application (2020-2025)
 Table 63. Global Inflammatory POCT Sales Market Share by Application (2026-2031)
 Table 64. Global Inflammatory POCT Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inflammatory POCT Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inflammatory POCT Revenue Market Share by Application (2020-2025)
 Table 67. Global Inflammatory POCT Revenue Market Share by Application (2026-2031)
 Table 68. Global Inflammatory POCT Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Inflammatory POCT Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Inflammatory POCT Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Inflammatory POCT Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Siemens Healthineers Company Information
 Table 81. Siemens Healthineers Description and Business Overview
 Table 82. Siemens Healthineers Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Siemens Healthineers Inflammatory POCT Product
 Table 84. Siemens Healthineers Recent Developments/Updates
 Table 85. BioMerieux Company Information
 Table 86. BioMerieux Description and Business Overview
 Table 87. BioMerieux Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. BioMerieux Inflammatory POCT Product
 Table 89. BioMerieux Recent Developments/Updates
 Table 90. Bio-Rad Laboratories Company Information
 Table 91. Bio-Rad Laboratories Description and Business Overview
 Table 92. Bio-Rad Laboratories Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bio-Rad Laboratories Inflammatory POCT Product
 Table 94. Bio-Rad Laboratories Recent Developments/Updates
 Table 95. Assure Tech Company Information
 Table 96. Assure Tech Description and Business Overview
 Table 97. Assure Tech Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Assure Tech Inflammatory POCT Product
 Table 99. Assure Tech Recent Developments/Updates
 Table 100. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
 Table 101. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
 Table 102. Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Product
 Table 104. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
 Table 105. Wuhan Easy Diagnosis Company Information
 Table 106. Wuhan Easy Diagnosis Description and Business Overview
 Table 107. Wuhan Easy Diagnosis Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Wuhan Easy Diagnosis Inflammatory POCT Product
 Table 109. Wuhan Easy Diagnosis Recent Developments/Updates
 Table 110. Getein Biotech Company Information
 Table 111. Getein Biotech Description and Business Overview
 Table 112. Getein Biotech Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Getein Biotech Inflammatory POCT Product
 Table 114. Getein Biotech Recent Developments/Updates
 Table 115. Beijing Hotgen Biotech Co.,ltd. Company Information
 Table 116. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
 Table 117. Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Product
 Table 119. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
 Table 120. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Company Information
 Table 121. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Description and Business Overview
 Table 122. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Product
 Table 124. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
 Table 125. Qingdao Hightop Biotech Co., Ltd. Company Information
 Table 126. Qingdao Hightop Biotech Co., Ltd. Description and Business Overview
 Table 127. Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Product
 Table 129. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
 Table 130. Goldsite Diagnostics Inc. Company Information
 Table 131. Goldsite Diagnostics Inc. Description and Business Overview
 Table 132. Goldsite Diagnostics Inc. Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Goldsite Diagnostics Inc. Inflammatory POCT Product
 Table 134. Goldsite Diagnostics Inc. Recent Developments/Updates
 Table 135. Genrui Biotech Inc Company Information
 Table 136. Genrui Biotech Inc Description and Business Overview
 Table 137. Genrui Biotech Inc Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Genrui Biotech Inc Inflammatory POCT Product
 Table 139. Genrui Biotech Inc Recent Developments/Updates
 Table 140. Hipro Biotechnology CO.,LTD Company Information
 Table 141. Hipro Biotechnology CO.,LTD Description and Business Overview
 Table 142. Hipro Biotechnology CO.,LTD Inflammatory POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hipro Biotechnology CO.,LTD Inflammatory POCT Product
 Table 144. Hipro Biotechnology CO.,LTD Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Inflammatory POCT Distributors List
 Table 148. Inflammatory POCT Customers List
 Table 149. Inflammatory POCT Market Trends
 Table 150. Inflammatory POCT Market Drivers
 Table 151. Inflammatory POCT Market Challenges
 Table 152. Inflammatory POCT Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inflammatory POCT
 Figure 2. Global Inflammatory POCT Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inflammatory POCT Market Share by Type: 2024 & 2031
 Figure 4. Based on Immunochromatography Product Picture
 Figure 5. Based on Chemiluminescence Product Picture
 Figure 6. Based on Microfluidic Chip Product Picture
 Figure 7. Global Inflammatory POCT Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Inflammatory POCT Market Share by Application: 2024 & 2031
 Figure 9. C-Reactive Protein (CRP) Test
 Figure 10. Procalcitonin (PCT) Test
 Figure 11. Interleukin 6 (IL-6) Test
 Figure 12. Serum amyloid A (SAA) Test
 Figure 13. Others
 Figure 14. Global Inflammatory POCT Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Inflammatory POCT Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Inflammatory POCT Sales (2020-2031) & (K Units)
 Figure 17. Global Inflammatory POCT Average Price (US$/Unit) & (2020-2031)
 Figure 18. Inflammatory POCT Report Years Considered
 Figure 19. Inflammatory POCT Sales Share by Manufacturers in 2024
 Figure 20. Global Inflammatory POCT Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Inflammatory POCT Players: Market Share by Revenue in Inflammatory POCT in 2024
 Figure 22. Inflammatory POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Inflammatory POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Inflammatory POCT Sales Market Share by Country (2020-2031)
 Figure 25. North America Inflammatory POCT Revenue Market Share by Country (2020-2031)
 Figure 26. United States Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Inflammatory POCT Sales Market Share by Country (2020-2031)
 Figure 29. Europe Inflammatory POCT Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Inflammatory POCT Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Inflammatory POCT Revenue Market Share by Region (2020-2031)
 Figure 37. China Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Inflammatory POCT Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Inflammatory POCT Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Inflammatory POCT Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Inflammatory POCT Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Inflammatory POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Inflammatory POCT by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Inflammatory POCT by Type (2020-2031)
 Figure 56. Global Inflammatory POCT Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Inflammatory POCT by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Inflammatory POCT by Application (2020-2031)
 Figure 59. Global Inflammatory POCT Price (US$/Unit) by Application (2020-2031)
 Figure 60. Inflammatory POCT Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart